"Antineoplastic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Substances that inhibit or prevent the proliferation of NEOPLASMS.
| Descriptor ID |
D000970
|
| MeSH Number(s) |
D27.505.954.248
|
| Concept/Terms |
Antineoplastic Agents- Antineoplastic Agents
- Agents, Antineoplastic
- Antineoplastic Drugs
- Drugs, Antineoplastic
- Antineoplastics
- Chemotherapeutic Anticancer Drug
- Drug, Chemotherapeutic Anticancer
- Antitumor Drugs
- Drugs, Antitumor
- Cancer Chemotherapy Agents
- Agents, Cancer Chemotherapy
- Chemotherapy Agents, Cancer
- Cancer Chemotherapy Drugs
- Chemotherapy Drugs, Cancer
- Drugs, Cancer Chemotherapy
- Chemotherapeutic Anticancer Agents
- Agents, Chemotherapeutic Anticancer
- Anticancer Agents
- Agents, Anticancer
- Antitumor Agents
- Agents, Antitumor
|
Below are MeSH descriptors whose meaning is more general than "Antineoplastic Agents".
Below are MeSH descriptors whose meaning is more specific than "Antineoplastic Agents".
This graph shows the total number of publications written about "Antineoplastic Agents" by people in this website by year, and whether "Antineoplastic Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 13 | 2 | 15 |
| 1997 | 8 | 1 | 9 |
| 1998 | 22 | 5 | 27 |
| 1999 | 9 | 9 | 18 |
| 2000 | 17 | 6 | 23 |
| 2001 | 23 | 6 | 29 |
| 2002 | 36 | 11 | 47 |
| 2003 | 30 | 11 | 41 |
| 2004 | 37 | 13 | 50 |
| 2005 | 31 | 19 | 50 |
| 2006 | 35 | 21 | 56 |
| 2007 | 44 | 16 | 60 |
| 2008 | 33 | 18 | 51 |
| 2009 | 40 | 24 | 64 |
| 2010 | 52 | 27 | 79 |
| 2011 | 64 | 18 | 82 |
| 2012 | 55 | 28 | 83 |
| 2013 | 54 | 24 | 78 |
| 2014 | 78 | 22 | 100 |
| 2015 | 84 | 34 | 118 |
| 2016 | 62 | 32 | 94 |
| 2017 | 59 | 27 | 86 |
| 2018 | 49 | 27 | 76 |
| 2019 | 41 | 26 | 67 |
| 2020 | 39 | 22 | 61 |
| 2021 | 48 | 16 | 64 |
| 2022 | 23 | 2 | 25 |
| 2023 | 42 | 0 | 42 |
| 2024 | 15 | 23 | 38 |
| 2025 | 16 | 5 | 21 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antineoplastic Agents" by people in Profiles.
-
Apoptosis-targeting BH3 mimetics: transforming treatment for patients with acute myeloid leukaemia. Nat Rev Clin Oncol. 2025 Nov; 22(11):847-868.
-
Individual patient data meta-analysis of NEPA versus aprepitant-based antiemetic regimens for preventing chemotherapy-induced nausea and vomiting. Future Oncol. 2025 Sep; 21(21):2823-2833.
-
Current paradigm of EGFRins20 in non-small cell lung cancer: A long way forward. Med. 2025 Sep 12; 6(9):100803.
-
Metabolic reprogramming in breast cancer: Pathways driving progression, drug resistance, and emerging therapeutics. Biochim Biophys Acta Rev Cancer. 2025 Oct; 1880(5):189396.
-
Nanoscale Donor-Acceptor Covalent Organic Frameworks for Mitochondria-Targeted Sonodynamic Therapy and Antitumor Immunity. J Am Chem Soc. 2025 Jul 23; 147(29):25622-25634.
-
Using Quantitative Approaches to Optimize Dosages for New Combinations and Subsequent Indications for Oncology Drugs. Clin Pharmacol Ther. 2025 Oct; 118(4):772-777.
-
Cellular hierarchies of embryonal tumors with multilayered rosettes are shaped by oncogenic microRNAs and receptor-ligand interactions. Nat Cancer. 2025 Jun; 6(6):1035-1055.
-
Driving Best Practices Throughout the Treatment Journey for Patients with NSCLC with Actionable Alterations: A Podcast Discussion. Adv Ther. 2025 Aug; 42(8):3591-3605.
-
3D genome organization shapes DNA damage susceptibility to platinum-based drugs. Nucleic Acids Res. 2025 May 22; 53(10).
-
Chemotherapy and the somatic mutation burden of sperm. JCI Insight. 2025 Jun 23; 10(12).